BioSpace News Archive

Rakovina Therapeutics Inc. announces that it may apply to the TSX Venture Exchange to extend the expiry date of 11,414,750 common share purchase warrants issued by the Company.

Tango Therapeutics, Inc. reported that it is aware of the current situation affecting Silicon Valley Bank, it is monitoring this situation closely and does not expect its exposure to SVB will require any change to its previously provided guidance that it has sufficient cash, cash equivalents and marketable securities to fund operations into 2025.

Zynex, Inc. (Nasdaq: ZYXI) today announced that the company will report fourth quarter and full-year 2022 financial results on Monday, March 13, 2023.

Science 37 Holdings, Inc., the industry-leading Metasite™, announced the granting of inducement equity awards under the Science 37 Holdings, Inc. 2022 Employment Inducement Incentive Award Plan.

Akumin Inc. (NASDAQ: AKU) (TSX: AKU) (“Akumin” or the “Company”) will host a conference call at 8:30 a.m. Eastern Time, March 17, 2023, to discuss its year-end 2022 financial results.